Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders

E-ISSN： 1873-5592|19|6|636-650

ISSN： 1389-4501

Source： Current Drug Targets, Vol.19, Iss.6, 2018-04, pp. : 636-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of -Adrenoceptor Agonists as Add-On Therapy for Multiple Sclerosis: Focus on Salbutamol (Albuterol)

By Makhlouf K. Weiner H.L. Khoury S.J.

CNS Drugs, Vol. 16, Iss. 1, 2002-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Levetiracetam as an Add-On Therapy in Patients with Refractory Epilepsy

By Sheehy Odile

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 493-503

Adis International

Access to resources Recommend Favorite

Oxidative Imbalance and Anxiety Disorders

Current Neuropharmacology, Vol. 12, Iss. 2, 2014-03 ,pp. : 193-204

Bentham Science Publishers

Access to resources Recommend Favorite

Pteridine Derivatives as Modulators of Oxidative Stress

Current Drug Metabolism, Vol. 3, Iss. 2, 2002-04 ,pp. : 203-209

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled treprostinil is an effective, well-tolerated add-on therapy for patients with pulmonary arterial hypertension (PAH) treated with bosentan

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite